AusPAR: Certolizumab pegol (rbe)
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
25 November 2015
| AusPAR | |
|---|---|
| Active Ingredient | Certolizumab pegol (rbe)
|
| Product Name | Cimzia
|
| Sponsor | UCB Australia Pty Ltd
|
| Submission Number | PM-2013-04590-1-3
|
| Submission Type | Major variation (extension of indications)
|
| Decision | Approved
|
| AusPAR Date | 2 November 2015
|
| Publication Date | 25 November 2015 |